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Abstract
Introduction: Shock index (SI) is a predictor of hemodynamic compromise in obstetric 
patients. The SI threshold for action is not well understood. We aimed to evaluate SI 
thresholds as predictors of outcomes in obstetric patients.
Material and methods: We undertook a prospective cohort study at three South 
African hospitals of women with postpartum hemorrhage (n = 283) or maternal sep‐
sis (n = 126). The “first” and “worst” SI following diagnosis were recorded. SI was 
compared with conventional vital signs as predictors of outcomes. The performance 
of SI <.9, SI .9‐1.69 and SI ≥1.7 to predict outcomes (maternal death; Critical Care Unit 
admission; major procedure; hysterectomy) and hemorrhage‐specific outcomes (low‐
est hemoglobin <70 g/l; blood transfusion ≥4 IU) were evaluated.
Results: “First” SI was one of two best performing vital signs for every outcome in 
postpartum hemorrhage and sepsis. In hemorrhage, risk of all outcomes increased with 
increasing “first” SI; for blood transfusion ≥4 IU odds ratio was 4.24 (95% confidence in‐
terval 1.25‐14.36) for SI ≥1.7 vs SI .9‐1.69. In sepsis, risk of all outcomes increased with 
increasing “worst” SI. Sensitivity, specificity, positive and negative predictive values of 
“first” SI <.9 vs SI ≥.9 for maternal death were 100.0%, 55.2%, 4.6% and 100.0%, re‐
spectively, in hemorrhage and 80.0%, 50.4%, 12.3% and 96.7%, respectively, in sepsis.
Conclusions: The shock index was a consistent predictor of outcomes compared 
with conventional vital signs in postpartum hemorrhage and sepsis. SI <.9 performed 
well as a rule‐out test and SI .9‐1.69 and SI ≥1.7 indicated increased risk of all out‐
comes in both cohorts. These thresholds may alert to the need for urgent interven‐
tion and prevent maternal deaths.
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1  | INTRODUC TION
Approximately 115 000 women die from postpartum hemor‐
rhage (PPH), maternal sepsis and abortion complications (often 
from hemorrhage or sepsis) annually, contributing to almost half 
of all maternal deaths.1 Most deaths are associated with delays 
in identifying hemodynamic compromise and escalating care2 and 
are avoidable.1,3 Early identification of compromise using vital sign 
measurement (commonly blood pressure [BP] and heart rate [HR]) 
is critical in preventing maternal mortality and morbidity. In low‐ 
and middle‐income countries, healthcare providers may not have 
access to devices measuring vital signs or the training to respond 
appropriately to abnormal vital signs. It is in these environments 
that 99% of maternal deaths occur.4 Efforts to improve access to 
accurate vital sign measurement and training to respond to abnor‐
mal vital signs may have a substantial impact on reducing maternal 
deaths.5
The shock index (SI), the ratio of HR to systolic BP, has been 
shown to be an early predictor of massive transfusion, Intensive 
Care Unit admission and death in non‐obstetric critically ill patients,6 
trauma7‐10 and sepsis.11 According to retrospective cohorts of women 
with PPH, SI has also been shown to be the most consistent predic‐
tor of adverse outcomes compared with individual conventional vital 
signs, including systolic BP12,13 and studies have proposed an upper 
limit of normal SI of .9 in PPH.12‐14 For use as an early warning system, 
thresholds of SI have been proposed (SI <.9, SI .9‐1.69 and SI ≥1.7), 
based on retrospective cohorts of women with PPH in both well‐
resourced and low‐resourced settings, to indicate increased risk of 
adverse outcomes.12,13 SI has not been evaluated in maternal sepsis 
or prospectively evaluated in PPH, and the previously proposed SI 
thresholds have not yet been prospectively validated.
This South African facility‐level study aimed to evaluate pro‐
spectively whether SI is a consistent predictor of adverse outcomes 
in both PPH and maternal sepsis and whether the previously deter‐
mined SI thresholds perform appropriately as predictors of adverse 
outcomes in both groups of women.
2  | MATERIAL AND METHODS
This prospective cohort study was undertaken between January 
2015 and May 2016 at three tertiary maternity units in South Africa 
(Groote Schuur, Tygerberg and Kimberley Hospitals). Women were 
eligible if they were diagnosed with either PPH or maternal sep‐
sis (antepartum or postpartum) during their admission, up until 
discharge from hospital. PPH was defined as an estimated blood 
loss ≥500 mL for vaginal deliveries and ≥1000 mL for cesarean de‐
liveries, as defined in studies from similar settings.15 Diagnosis of 
maternal sepsis was based on clinical features determined by the 
woman's healthcare provider and documented in the patient notes.
Existing BP devices were replaced by the Microlife® CRADLE 
Vital Signs Alert (VSA), a vital signs device that measures BP and heart 
rate, is suitable for use in low‐resource settings16 and is validated as 
accurate for use in pregnancy, including preeclampsia and low BP in 
pregnancy.16‐18 The device incorporates a traffic light early‐warning 
system triggering a green, yellow or red light according to categories 
of SI: SI <.9, SI .9‐1.69 and SI ≥1.7, respectively, to alert healthcare pro‐
viders to abnormalities in vital signs. Anesthetic and recovery areas 
were allowed access to additional BP devices integrated into existing 
machines, if requested. Consequently, almost all women had access to 
the CRADLE VSA and traffic lights triggered by SI. Clinicians used the 
HR and BP measurements to determine clinical decisions and managed 
women according to local practice. They were not masked to the traffic 
light alerts but were not trained to escalate care according to them.
Key message
Postpartum hemorrhage and sepsis are the leading causes 
of maternal deaths. The shock index is a useful predictor of 
adverse outcomes in postpartum hemorrhage and sepsis. 
Shock index thresholds may alert to the need for urgent 
intervention and prevent maternal deaths.
F I G U R E  1   Flow diagram of participants
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The “first” and the “worst” sets of BP and HR taken following 
diagnosis of PPH or sepsis were recorded. The “first” set was defined 
as those documented immediately after diagnosis and the “worst” 
set as the set corresponding to the highest SI, documented at any 
time between diagnosis and discharge (or maternal death). The pre‐
defined outcomes included maternal death, maternal Critical Care 
Unit (CCU) admission, major surgical or invasive procedures and 
emergency hysterectomy. CCU was defined as a specified Critical 
Care area providing at least additional monitoring and interven‐
tions.19 Major surgical or invasive procedures were defined as 
uterine balloon tamponade, artery ligation/embolization/clamping, 
hemostatic brace suture, emergency laparotomy for hemorrhage, 
other procedures related to sepsis or emergency hysterectomy. 
For hemorrhage, additional outcomes included lowest hemoglobin 
following diagnosis <70 g/L and blood transfusion ≥4 IU. Perinatal 
complications were recorded but not treated as outcomes because, 
by definition, diagnosis of PPH and most sepsis diagnoses were 
made following delivery. We have previously demonstrated that SI 
is not influenced by regional anesthesia or mode of delivery, so this 
data was not collected.20
Data were extracted from patient notes reviewed by a local re‐
searcher. Data quality checks were undertaken on the database by 
an external researcher. Discrepancies were adjudicated by an obste‐
trician. Women with missing vital signs were excluded; women with 
missing outcomes were included but not analyzed for the outcome 
for which the data were missing.
2.1 | Statistical analyses
Predefined analysis aimed to determine whether SI was selected as a 
consistent predictor of adverse outcomes. This was calculated using 
area under the receiver operating characteristic curve (AUROC) val‐
ues (95% confidence intervals [CI]) for “first” SI and conventional 
vital signs (HR, systolic BP, diastolic BP, mean arterial pressure, and 
pulse pressure) for predicting the predefined outcomes. Mean ar‐
terial pressure was defined as (2× diastolic BP + systolic BP)/3 and 
pulse pressure was defined as systolic BP − diastolic BP. Predictor 
equality of AUROCs across the outcomes was tested using unad‐
justed chi‐square analysis.
The ability of the “first” and “worst” SI categories (SI <.9, SI 
.9‐1.69 and SI ≥1.7) to predict the risk of each outcome was eval‐
uated using post‐test probabilities for each category, odds ratios 
of SI .9‐1.69 vs SI <.9 and SI ≥1.7 vs SI .9‐1.69, and non‐para‐
metric trend testing of change in risk across the SI categories.21 
Post‐test probability (with 95% confidence intervals) was defined 
as the proportion of women with vital signs falling within each 
category who have the outcome. The 95% CIs were included to 
allow for generalization from the sample to the population with 
similar characteristics. Post‐test probability was used to evaluate 
the performance of the three categories (SI <.9, SI .9‐1.69, and SI 
≥1.7), rather than traditional predictive testing using sensitivity, 
specificity, positive predictive value and negative predictive test‐
ing, which is only appropriate when testing one threshold/two cat‐
egories.22 Sensitivity, specificity, and positive predictive value and 
negative predictive testing were used to evaluate the test perfor‐
mance of the single threshold of SI <.9 as a rule‐out test at “first” 
vital signs measurement following diagnosis for the prediction of 
the two most severe adverse outcomes (emergency hysterectomy 
and maternal death). Separate analyses were performed for PPH 
and maternal sepsis. Women with both diagnoses were included 
in both groups.
A post‐hoc power calculation was performed for two principal 
outcomes, CCU admission and emergency hysterectomy. The rate of 
CCU admission could be estimated to within 5.9% and 9.1% of the true 
value, for PPH and sepsis, respectively, with 95% confidence. The rate 
of emergency hysterectomy could be estimated to within 3.9% and 
6.2% of the true value, for PPH and sepsis, respectively, with 95% con‐
fidence. Statistical analysis was performed in the statistical package 
TA B L E  1   Demographic, admission, delivery, perinatal outcomes 









Age at delivery, y 29.7 ± 6.2 27.0 ± 6.6
Body mass index, kg/m2 30.9 ± 7.9 31.1 ± 9.7
Multiparous 225, 79.5% 70, 56.0%
Delivery details
Gestation at delivery, 
weeks
36.3 (32.0‐39.0) 36.6 (32.9‐38.9)
Preterm birth <34 wk 97, 34.3% 39, 31.5%
Preterm birth <37 wk 155, 54.8% 65, 52.4%
Mode of delivery: 
Cesarean section
129, 45.6% 100, 80.0%
Diagnosis details
Estimated blood loss, mL 1100 
(800‐1500)
—
Time from delivery to 
diagnosis, minutes








Blood cultures taken NA 114, 90.5%




Stillbirth 95, 33.6% 16, 12.7%
Early neonatal death 8, 2.8% 3, 2.4%
Late neonatal death 0, 0% 0, 0%
Mean ± standard deviation, median (interquartile range) and n, percent‐
age are shown.
NA, not applicable.
aFor postnatal sepsis only. 
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STATA (version 11.2). The conventional significance level was set at 
P ≤ .05. The study was reported in accordance with STrengthening 
the Reporting of OBservational studies in Epidemiology (STROBE) 
guidelines.
Ethical approval
The study was approved by the Stellenbosch University Ethics 
Committee (N14/06068, June 2014), University of Cape Town 
Ethics Committees (410/2014, July 2014) and the University of the 
Free State Ethics Committee (230408‐011, September 2014). Local 
ethics committees at two of the three sites (Tygerberg Hospital and 
Kimberley Hospital) required individual informed written consent to 
be obtained before the woman was enrolled in the study (or waiver 
of consent was granted if the woman was unconscious). Institutional‐
level agreement for the study was given at the third site—Groote 
Schuur Hospital (ie, individual‐level consent was not required).
3  | RESULTS
A total of 283 women with PPH and 126 women with sepsis were 
eligible, consented and were included in the analyses (Figure 1). The 
number of women who declined to take part was not documented. 
Thirteen women were included in both analyses, having both 
diagnoses.
Participant characteristics are shown in Table 1. Mean body 
mass index ± standard deviation was 30.9 ± 7.9 for those with PPH 
and 31.1 ± 9.7 for those with maternal sepsis. Cesarean section 
was more common in women with sepsis: 100 women (80%) with 
maternal sepsis delivered by cesarean section compared with 129 
women (45.6%) with PPH. Our sites had high cesarean section 
rates in keeping with referral centers (33%‐55%), but the high rates 
in our study population, along with lower gestational age, are in 
keeping with the adverse obstetric outcomes seen in the study 
population. In women with sepsis, blood cultures were taken in 114 
women (90.5%); of those, 35 women (30.7%) had positive blood 
culture results.
Vital sign results are shown in Table 2. The mean (standard de‐
viation) “first” and “worst” SI after diagnosis of PPH were .95 ± .32 
and 1.12 ± .29, respectively; the mean (standard deviation) “first” 
and “worst” SI after diagnosis of sepsis were .99 ± .82 and 1.12 ± .27, 
respectively. In all, 206 women with PPH (72.8%) had an SI .9‐1.69 as 
their “worst” SI following diagnosis and 17 women (6.0%) had an SI 
≥1.7 as their “worst” SI following diagnosis.
Table 3 shows the incidence of each outcome. Six women 
(2.1%) with PPH and 10 women (7.9%) with maternal sepsis died 
while admitted. Of those with PPH, the lowest hemoglobin was 
<70 g/L in 106 women (37.6%), and 92 women (32.5%) received 
≥4 IU of blood. A total of 106 women (37.5%) with PPH and 
61 women (48.4%) with sepsis were admitted to CCU. Twenty‐
four women (8.5%) with PPH and 10 women (7.9%) with sepsis 
underwent emergency hysterectomy. Although our blood loss 
estimates were relatively low, the high rates of transfusion in‐
dicate severe hemorrhage and may reflect underestimation of 
blood loss.
According to AUROC values, SI at “first” vital sign measure‐





sis (n = 126)
“First” SI after diagnosis .95 ± .32 .99 ± .82
“First” HR after diagnosis 104 ± 19 114 ± 19
“First” systolic BP after diagnosis 116 ± 24 126 ± 22
Time from diagnosis to “first” SI, minutes 15 (0‐44) 0 (0‐0)
“First” SI category
SI <.9 153, 54.1% 60, 48.4%
SI .9‐1.69 116, 41.0% 63, 50.8%
SI ≥1.7 14, 4.9% 1, .8%
Worst” SI after diagnosis 1.12 ± .29 1.12 ± .27
Worst” HR after diagnosis 120 ± 18 130 ± 20
Worst” systolic BP after diagnosis 97 ± 15 104 ± 15
Time from diagnosis to “worst” SI, 
hours
4.23 (.42‐16.96) 13.8 
(1.73‐46.75)
“Worst” SI category
SI <.9 60, 21.2% 24, 19.4%
SI .9‐1.69 206, 72.8% 94, 75.8%
SI ≥1.7 17, 6.0% 6, 4.8%
Mean ± standard deviation or n, percentage or median (interquartile range) are shown.
Abbreviations: SI, shock index; HR, heart rate.
TA B L E  2   “First” and “worst” shock 
index values following diagnosis of 
hemorrhage/sepsis and their timing with 
respect to diagnosis
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signs for every adverse outcome in both hemorrhage and sepsis 
groups (Table 4). For example, for predicting risk of emergency 
hysterectomy, SI gave an AUROC of .79 (95% CI; .70‐.88) in PPH 
and .73 (95% CI; .60‐.87) in maternal sepsis. SI was selected as the 
most consistent predictor across the outcomes for both groups 
of women. Tables 5 and 6 show the frequency and percentage of 
outcomes across the SI categories, together with the post‐test 
probabilities, odds ratios and the non‐parametric trend test, for 
both groups.
In PPH, statistical testing for trend for every outcome showed a 
significant increase in risk with higher SI categories at “first” mea‐
surement. This was also true for the “worst” SI categories (apart 
from a nonsignificant trend for maternal death). In sepsis, only one 
woman had an SI ≥1.7 at “first” vital signs and this woman had no 
adverse outcomes, limiting the ability to test for trend in this group. 
For “worst” vital signs in women with sepsis, statistical testing for 
trend for every outcome showed a significant increase in risk with 
increasing SI categories. The small number of septic women with 
“worst” SI ≥1.7 were associated with very high risks, with one‐third 
(2 of 6) ending in maternal death. Table 7 shows the sensitivity, 
specificity, positive predictive value and negative predictive value 
of “first” SI <.9 in PPH and sepsis. There were no maternal deaths, 
major procedures or emergency hysterectomies in women with 
“first” SI <.9.
Sensitivity analysis was performed to determine whether a 
more stringent categorization of sepsis (the administration of in‐
travenous antibiotics) altered the findings. The additional analysis 
showed similar odds ratios (95% CI) for all the outcomes for both 
“first” and “worst” SI categories (data not presented). Therefore, 
the original definition of sepsis was used to maintain power.
4  | DISCUSSION
SI was the most consistent predictor, compared with individual con‐
ventional vital signs, of all adverse outcomes in women with PPH 
and maternal sepsis, two of the leading causes of maternal mortality 
and morbidity.
Previously determined “abnormal” SI categories (SI .9‐1.69 and SI 
≥1.7) were significantly associated with a number of severe adverse 
outcomes in both cohorts of women. Test performance statistics 
showed the previously determined upper limit of normal (SI <.9) to 
be a good rule‐out test for maternal death and emergency hysterec‐
tomy in both cohorts of women.
The SI category at “first” vital signs measurement following PPH 
diagnosis was predictive of all outcomes, including maternal death 
and emergency hysterectomy, with a stepwise increase in risk from 
SI <.9 to SI .9‐1.69 to SI ≥1.7. The SI category at “worst” vital signs 
measurement following maternal sepsis diagnosis was also predic‐
tive of all outcomes. As with all vital signs, change over time may be 
important.
To improve generalizability of the results, multiple centers, lim‐
ited exclusion criteria and multiple, robust and severe outcomes 
to assess prediction were used. Sepsis was defined according to 
clinical features determined by the woman's healthcare provider. 
Maternal sepsis has been poorly defined in the literature.23 Only 
in 2017, after the completion of this study, did the World Health 
Organization convene a multidisciplinary international panel of 48 
experts to set a definition of maternal sepsis. Maternal sepsis is 
now defined as organ dysfunction resulting from infection during 
pregnancy, childbirth, post‐abortion or postpartum period.24 We 
could not determine whether our inclusion criteria correlate with 
this new definition; however, sensitivity analysis using an alterna‐
tive categorization of sepsis showed similar findings.
Our objective was to determine whether SI thresholds could 
aid decision‐making for healthcare providers with limited train‐
ing and resources. Tertiary centers were chosen to ensure sam‐
ple size and corresponding outcome rates were high enough for 
TA B L E  3   Mean ± standard deviation or n, percentage of adverse 









Maternal death 6, 2.1% 10, 7.9%
Lowest hemoglobin following 
diagnosis, g/L
77 ± 19 —
Lowest hemoglobin <70 g/L fol‐
lowing diagnosis
106, 37.6% —
Drop in hemoglobin, g/L (n = 247) 27 ± 21 —




Blood transfusion 198, 70.0% —
Blood transfusion ≥4 IU, n (% of 
all women)
92, 32.5% —
Number of IU 3.9 ± 2.6 —
Critical Care Unit admission 106, 37.5% 61, 48.4%
Procedures
Any 90, 31.8% 30, 23.8%
Major surgical or invasive 
procedure
66, 23.3% 55, 36.5%
Perineal repair 31, 11.0% 3, 2.4%
Manual removal of placenta 14, 4.9% 1, .8%
Uterine balloon tamponade 14, 4.9% 2, 1.6%
Artery ligation/embolization/
clamping
7, 2.5% 3, 2.4%
Hemostatic brace suturing 5, 1.8% 2, 1.6%
Emergency laparotomy for 
hemorrhage
15, 5.3% 1, .8%
Other procedures related to 
sepsis
1, .4% 10, 7.9%
Emergency hysterectomy 24, 8.5% 10, 7.9%
IU, international units.
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meaningful analysis. It would have been considerably more chal‐
lenging to undertake such a study in community low‐ and mid‐
dle‐income countries, where the device is likely to show greatest 
benefit; outcome rates would have been fewer and a much larger 
sample size would have been required. Although the number of 
women with SI ≥1.7 was relatively small, severe adverse outcomes 
were common, unique in comparison with similar maternal health 
studies.
TA B L E  4   Performance of “first” vital sign parameters to predict adverse clinical outcomes among women with postpartum hemorrhage 
and maternal sepsis




PPH 0.86 (0.73‐0.98) 0.85 (0.76‐0.93) 0.67 (0.41‐0.94) 0.54 (0.19‐0.88)a 0.83 (0.70‐0.97) 0.59 (0.26‐0.92)a
Sepsis 0.71 (0.55‐0.86) 0.70 (0.54‐0.87) 0.53 (0.33‐0.72)a 0.59 (0.33‐0.85) 0.52 (0.28‐0.76) 0.56 (0.33‐0.78)
Critical Care Unit admission
PPH 0.68 (0.62‐0.75) 0.60 (0.53‐0.67)a 0.67 (0.60‐0.73) 0.62 (0.56‐0.69)a 0.60 (0.53‐0.67)a 0.65 (0.58‐0.71)
Sepsis 0.59 (0.48‐0.69) 0.61 (0.51‐0.71) 0.50 (0.39‐0.60)a 0.53 (0.42‐0.63) 0.52 (0.41‐0.62) 0.51 (0.41‐0.61)
Hysterectomy
PPH 0.79 (0.70‐0.88) 0.71 (0.60‐0.82)a 0.73 (0.64‐0.82) 0.66 (0.57‐0.75)a 0.63 (0.52‐0.74)a 0.70 (0.61‐0.79)a
Sepsis 0.73 (0.60‐0.87) 0.70 (0.52‐0.87) 0.59 (0.45‐0.73) 0.59 (0.39‐0.78) 0.58 (0.36‐0.81) 0.58 (0.36‐0.81)
Lowest hemoglobin <70 g/L 
(PPH)
0.61 (0.55‐0.68) 0.63 (0.56‐0.69) 0.54 (0.47‐0.61)a 0.51 (0.44‐0.58)a 0.58 (0.51‐0.65) 0.52 (0.45‐0.59)a
Blood transfusion ≥4 IU  
(PPH)
0.65 (0.58‐0.72) 0.65 (0.58‐0.71) 0.58 (0.50‐0.65)a 0.52 (0.44‐0.59)a 0.59 (0.52‐0.67) 0.54 (0.46‐0.61)a
Major procedure (sepsis) 0.64 (0.52‐0.75) 0.53 (0.40‐0.67)a 0.62 (0.51‐0.73) 0.56 (0.44‐0.68) 0.63 (0.51‐0.76) 0.58 (0.46‐0.69)
AUROC values given as AUROC (95% CI). In bold: highest two AUROC values for each outcome. Results of significance testing for equality of 
AUROCs using unadjusted chi‐square test, with shock index as reference.
aSignificantly worse than shock index (P < 0.05). 
TA B L E  5   Frequency and post‐test probability of outcomes in women with “first” and “worst” SI <0.9, SI 0.9‐1.69, and SI ≥1.7 following 
hemorrhage diagnosis, odds ratios of SI 0.9‐1.69 vs SI <0.9 and SI ≥1.7 vs SI 0.9‐1.69 and non‐parametric trend test for worsening SI 










SI <.9 (153) 0 0 (0‐2.4) 50 32.9 (25.5‐41.0) 39 25.5 (18.8‐33.2) 39 25.5 (18.8‐33.1) 3 2.0 (0.4‐5.6)
SI .9‐1.69 (116) 5 4.3 (1.4‐9.8) 44 37.9 (29.1‐47.4) 43 37.1 (28.3‐46.5) 56 48.3 (38.9‐57.7) 17 14.7 (8.8‐22.4)
SI ≥1.7 (14) 1 7.1 (.2‐33.9) 12 85.7 (57.2‐98.2) 10 71.4 (41.9‐91.6) 11 78.6 (49.2‐95.3) 4 28.6 (8.4‐58.1)
SI .9‐1.69 vs SI <.9 OR a 1.3 (0.8‐2.1) 1.7 (1.0‐2.9) 2.7 (1.6‐4.6) 8.59 (2.5‐30.1)
SI ≥1.7 vs SI .9‐1.69 OR 1.7 (.2‐15.8) 9.8 (2.1‐46.0) 4.2 (1.3‐14.4) 3.9 (1.0‐14.8) 2.3 (0.7‐8.3)
P 0.006 0.004 0.001 <0.001 <0.001
“Worst” vital signs
Post‐test probability
SI <.9 (60) 0 0 (0‐6.0) 19 32.2 (20.6‐45.6) 17 28.3 (17.5‐41.4) 9 15.0 (7.1‐26.6) 1 1.7 (0‐8.9)
SI .9‐1.69 (206) 5 2.4 (.8‐5.6) 74 35.9 (29.4‐42.9) 63 30.6 (24.4‐37.4) 84 40.8 (34.0‐47.8) 18 8.7 (5.3‐13.5)
SI ≥1.7 (17) 1 5.9 (.1‐28.7) 13 76.5 (50.1‐93.1) 12 70.6 (44.0‐89.7) 13 76.5 (50.1‐93.1) 5 29.4 (10.3‐56.0)
SI .9‐1.69 vs SI <.9 OR a 1.2 (.6‐2.2) 1.1 (.6‐2.1) 3.9 (1.8‐8.4) 5.7 (0.7‐43.2)
SI ≥1.7 vs SI .9‐1.69 OR 2.5 (.3‐22.8) 5.8 (1.8‐18.4) 5.5 (1.8‐16.1) 4.7 (1.5‐15.0) 4.4 (1.4‐13.7)
P 0.115 0.016 0.023 <0.001 0.001
Post‐test probability values are given as n, % (95% confidence interval). Odds ratios given as OR (95% confidence intervals). Values in bold indicate 
statistical significance. All P‐values are based on the non‐parametric test for trend.
aNot calculable due to 0%. 
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The traffic light early‐warning system and BP and HR values 
were visible to healthcare providers (as it was not possible to mask 
healthcare professionals to the lights and not ethical to withhold 
the absolute numbers). Healthcare providers could escalate care 
in response to the traffic lights that were triggered according to SI 
categories (although SI values were not displayed on the device); 
however, healthcare providers received no specific training on es‐
calation of care according to the traffic lights. Therefore, outcomes 
may have improved in response to BP and HR, and to a lesser ex‐
tent, in response to the traffic lights. As we have found significant 
associations between the SI categories and adverse outcomes, not 
only do our results remain valid, but arguably the association would 
likely have been even stronger if clinicians were masked to the traf‐
fic lights.
Our study reinforces the role of SI as a consistent marker of 
compromise in obstetrics. A 2013 systematic review assessing the 
association between vital signs and blood loss identified three ob‐
stetric studies involving SI.25 All three studies included only women 
in early pregnancy and only one was deemed of high methodolog‐
ical quality.26 In that study, SI performed better than all individual 
conventional vital signs for predicting ruptured ectopic pregnancy, 
with an AUROC of .84 (95% CI; .78‐.88).26 Since the systematic 
TA B L E  6   Frequency and post‐test probability of outcomes in women with “first” and “worst” SI <.9, SI .9‐1.69, and SI ≥1.7 following sepsis 
diagnosis, odds ratios of SI .9‐1.69 vs SI <.9 and SI ≥1.7 vs SI .9‐1.69 and non‐parametric trend test for worsening SI category (SI <.9 to SI 
.9‐1.69 to SI ≥1.7)
Outcomes Maternal death
Critical Care Unit 
admission Major procedure Hysterectomy
“First” vital signs
Post‐test probability
SI <0.9 (60) 2 3.3 (0.4‐11.5) 23 38.3 (26.1‐51.8) 9 15.0 (7.1‐26.6) 2 3.3 (0.4‐11.5)
SI 0.9‐1.69 (64) 8 12.5 (5.6‐23.2) 37 57.8 (44.8‐70.1) 16 25.0 (15.0‐37.4) 8 12.5 (5.6‐23.2)
SI ≥1.7 (1) 0a 0a 0a 0a
SI 0.9‐1.69 vs SI <.9 OR 4.14 (0.84‐20.36) 2.20 (1.07‐4.52) 1.89 (0.76‐4.68) 4.14 (0.84‐20.36)
SI ≥1.7 vs SI .9‐1.69 OR a a a a
P 0.083 0.065 0.226 0.083
“Worst” vital signs
Post‐test probability
SI <.9 (24) 0a 7 29.2 (12.6‐51.1) 0a 0a
SI .9‐1.69 (95) 8 8.4 (3.7‐15.9) 49 51.6 (41.1‐62.0) 23 24.2 (16.0‐34.1) 8 8.4 (3.7‐15.9)
SI ≥1.7 (6) 2 33.3 (4.3‐77.8) 4 66.7 (22.2‐95.7) 2 33.3 (4.3‐77.8) 2 33.3 (4.3‐77.8)
SI .9‐1.69 vs SI <.9 OR a 2.59 (0.98‐6.81) a a
SI ≥1.7 vs SI .9‐1.69 OR 5.44 (0.86‐34.42) 1.88 (0.33‐1.74) 1.57 (0.27‐9.11) 5.44 (0.86‐34.42)
P 0.016 0.032 0.008 0.016
Post‐test probability values are given as n, % (95% confidence interval), odds ratios given as OR (95% confidence intervals), values in bold indicate 
statistical significance. All P‐values are based on the non‐parametric test for trend. Major procedures included uterine balloon tamponade, artery 
ligation/embolization/clamping, hemostatic brace suture, emergency laparotomy for hemorrhage, other procedure related to sepsis, emergency 
hysterectomy.
aNot calculable due to 0%. 
TA B L E  7   Test performance statistics for “first” SI <.9 in prediction of adverse outcomes in women with postpartum hemorrhage or 
maternal sepsis
Outcomes
PPH Sepsis PPH Sepsis
Maternal death total N = 6 Maternal death N = 10 Hysterectomy N = 24 Hysterectomy N = 10
Sensitivity (%) n/N 100.0 (54.1‐100.0) 6/6 80.0 (44.4‐97.5) 8/10 87.5 (67.6‐97.3) 21/24 80.0 (44.4‐97.5) 8/10




PPV (%) n/N 4.6 (1.7‐9.8) 6/130 12.3 (5.5‐22.8) 8/65 16.2 (10.3‐23.6) 21/130 12.3 (5.5‐22.8) 8/65
NPV (%) n/N 100.0 (97.6‐100.0) 
153/153




PPH, postpartum hemorrhage; PPV, positive predictive value; NPV, negative predictive value.
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review, two other retrospective obstetric studies have suggested 
SI to be a reliable marker of deterioration. However, both studies 
included only women with PPH, with limited statistical analysis 
and fewer, less meaningful clinical outcomes.14,27
Our research team previously performed two retrospective pre‐
diction studies to evaluate SI and conventional vital signs as predic‐
tors of adverse outcomes in women with PPH (high‐ and low‐income 
settings) and to develop potential traffic light early‐warning system 
thresholds for the CRADLE VSA.12,13 The utility of SI in maternal 
sepsis has not previously been explored. This prospective study has 
confirmed that SI was one of the two best performing vital signs 
across the outcomes in PPH and maternal sepsis. The study also val‐
idated the previously determined SI thresholds in women with PPH 
and sepsis. The pathophysiology and clinical courses of these con‐
ditions differ and SI varies from minute to minute in each woman. 
Despite this, and in this study, one‐off SI values consistently pre‐
dicted a variety of severe adverse outcomes in both conditions.
The previously proposed upper limit of normal (SI <.9, green 
traffic light) performed well as a rule‐out test, according to pre‐
dictive analysis statistics. SI .9‐1.69 and SI ≥1.7 corresponded to 
stepwise increased risk of multiple outcomes in both cohorts of 
women. For PPH, the “first” SI following diagnosis was most useful, 
although both “first” and “worst” had predictive value. For mater‐
nal sepsis, the “worst” rather than the “first” SI following diagnosis 
was most useful. These findings reflect the clinical course of each 
condition, with complications of hemorrhage evolving more quickly 
than in sepsis. Complications of sepsis tend to evolve more insid‐
iously and repeated measurements may be more useful in sepsis.
The need for an obstetric early warning system is not only relevant 
for low‐ and middle‐income countries. The latest UK Confidential 
Enquiries into Maternal Deaths and Morbidity highlights that avoid‐
able maternal deaths and near‐misses are often related to delays 
in recognition of hemodynamic compromise.28 Modified early ob‐
stetric warning system charts are recommended by the report and 
are now commonplace internationally. Despite this, a standardized 
modified early obstetric warning system does not exist and the ev‐
idence for their thresholds is limited.29 They are complicated to use 
and inappropriate for low‐resource settings, where temperature and 
oxygen saturation is often not routinely measured.
5  | CONCLUSION
SI thresholds evaluated in this study may aid decision‐making by 
healthcare providers caring for women with PPH or maternal sep‐
sis in low‐resource settings, allowing for earlier interventions for 
those at highest risk of adverse outcomes. These thresholds have 
been incorporated into the CRADLE VSA traffic light early‐warn‐
ing system, together with conventional hypertension thresholds 
for women with hypertension disorders of pregnancy. A similar 
study of the performance of the early‐warning system in preec‐
lampsia was also undertaken.30 By assisting in the prediction for 
all three conditions, the CRADLE VSA could identify women at 
greatest risk of the three leading causes of maternal mortality and 
morbidity worldwide. To confirm the value of SI there is a need for 
more data from low‐income settings where adverse outcomes are 
more prevalent.
Although recognition of the need for intervention is but one as‐
pect of a functioning health system, it is the gateway to that system. 
We are undertaking a stepped‐wedge randomized control trial to 
assess whether a maternal mortality and morbidity are reduced in 
10 low‐income sites, introducing the CRADLE VSA and a simple ed‐
ucation package at community‐, clinic‐ and hospital‐levels.
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